Opinion

MSP Recovery Claims, Series LLC v. Mallinckrodt Ard Inc.

Court
District Court, N.D. Illinois
Filed
Apr 6, 2020
Cited by
0 cases
Authority
More cited than 20.9%

compelling depositions of Chairman and other executives because they were familiar with the pricing policies of Sony’s motion picture subsidiary that were relevant to plaintiff’s antitrust claim and had some knowledge of allegedly anticompetitive practices

How later courts described this case

  • compelling depositions of Chairman and other executives because they were familiar with the pricing policies of Sony’s motion picture subsidiary that were relevant to plaintiff’s antitrust claim and had some knowledge of allegedly anticompetitive practices
  • finding that one rationale for barring deposition of an apex witness “is that high level executives are vulnerable to numerous, repetitive, harassing, and abusive depositions, and therefore need some measure of protection from the courts”
  • “Federal courts have permitted thedepositions of high level executives when conduct and knowledge at the highest corporate levels of the defendant are relevant in the case.”
  • finding that information concerning corporate motive or intent resides with executives with greatest level of authority

Written by the judges who cited it.

The opinion

IN THE UNITED STATES DISTRICT COURT

FOR THE NORTHERN DISTRICT OF ILLINOIS

WESTERN DIVISION

City of Rockford, )

)

Plaintiff, )

) Case No. 17 CV 50107

v. )

) Magistrate Judge Lisa A. Jensen

Mallinckrodt ARD, Inc., et al., )

)

Defendants. )

MSP Recovery Claims, Series LLC, et al., )

)

Plaintiffs, )

) Case No. 20 CV 50056

v. )

) Magistrate Judge Lisa A. Jensen

Mallinckrodt ARD, Inc., et al., )

)

Defendants. )

MEMORANDUM OPINION AND ORDER

Defendants Mallinckrodt ARD, Inc. and Mallinckrodt PLC (“Mallinckrodt”) have moved

for a protective order to preclude the deposition of Mallinckrodt PLC’s President and CEO Mark

Trudeau. Rockford Dkt. 328; MSP Dkt. 283.1 Defendants Express Scripts Holding Co., Express

Scripts, Inc., CuraScript, Inc., Accredo Health Group, Inc., and United BioSource LLC (“Express

Scripts”) have moved for a protective order to prevent the depositions of George Paz, the former

CEO and Chairman of the Board of Express Scripts, Inc., and Tim Wentworth, the current

President of Express Scripts Holding Co. and former President and CEO of Express Scripts, Inc.

1Plaintiff City of Rockford filed a complaint in Case No. 17 CV 50107 (“Rockford”). Plaintiffs MSP

Recovery Claims, Series LLC, MAO-MSO Recovery, II, LLC, Series PMPI, and MSPA Claims 1, LLC

filed a second amended complaint in Case No. 20 CV 50056 (“MSP”).On March 23, 2020, the

Honorable John Z. Lee dismissed MSP’samended complaint without prejudice and allowed MSPleave to

file a second amended complaint within 45 days. MSPDkt. 320.

Rockford Dkt. 326; MSP Dkt. 281. For the following reasons, the Court denies their motions.

Status hearing remains set for May 7, 2020 at 2:30 p.m.

ANALYSIS2

Federal Rule of Civil Procedure 26(b)(1) provides that a party may “obtain discovery

regarding any nonprivileged matter that is relevant to any party’s claim or defense.” Rule 26(c)(1)

allows district courts, for good cause, to issue a protective order limiting discovery to protect a

party from oppression, undue burden or expense. Fed. R. Civ. P. 26(c)(1). “Before restricting

discovery, the court should consider ‘the totality of the circumstances, weighing the value of the

material sought against the burden of providing it,’ and taking into account society’s interest in

furthering ‘the truthseeking function’ in the particular case before the court.” Patterson v. Avery

Dennison Corp., 281 F.3d 676, 681 (7thCir. 2002).

The party seeking protection from discovery bears the burden of presenting “a particular

and specific demonstration of fact” as to the need for that protection. See Gulf Oil Co. v. Bernard,

452 U.S. 89, 102 n.16 (1981) (citations omitted); see alsoNucap Indus. Inc. v. Robert Bosch LLC,

No. 15 CV 2207, 2017 WL 6059770, at *2 (N.D. Ill. Dec. 7, 2017) (collecting cases). A strong

showing is required before a party will be denied entirely the right to take a deposition. Nucap,

2017 WL 6059770, at *4 (“[C]ompletely prohibiting a deposition is an extraordinary measure.”).

This burden does not shift simply because a party seeks to prevent the deposition of an

apex witness (i.e., a high-ranking executive). See Nucap, 2017 WL 6059770, at *2. In Nucap, the

defendants argued that even though they sought a protective order to prevent the deposition of an

apex witness, the plaintiff bore the burden of proving that the apex witness has unique, non-

cumulative, first-hand relevant knowledge that cannot be maintained by other less intrusive means.

The defendants relied on the Seventh Circuit case of Patterson, 281 F.3d 676, to support their

argument that when an apex witness is involved the burden of proof shifts. The court disagreed.

“[T]his view misreads Patterson and contradicts the well-established principle that the party

seeking protection from discovery bears the burden of presenting ‘a particular and specific

demonstration of fact’ as to the need for that protection.” See Nucap, 2017 WL 6059770, at *2

(citations omitted).

2Although MSP’samended complaint was dismissed without prejudice, MSP has informed the Court that

itintendsto file a second amended complaint. Without an operative compliant in the MSPcase, this

ruling will applyonly to the claims outlined in Rockford’s second amended complaint. However,due to

thesignificant overlap among theclaims asserted by both Rockford and MSP,should MSP file a second

amended complaintthat is similar to its amended complaint, the Court strongly encourages the parties to

meet and confer on the applicability of this ruling to the newly filed MSP complaint before refiling a

discovery motion on this topic.

While the Seventh Circuit in Patterson did not shift the burden in cases involving apex

witnesses, they did acknowledge that in determining whether to allow an apex deposition courts

may weigh the value of the material sought against the burden of providing it and in doing so may

take into consideration the burden that a deposition of an apex witness would place on the

company, other reasonably available means of discovery, and the amount in controversy in the

case. Patterson, 281 F.3d at 682. While not specifically adopted by the Seventh Circuit, some

district courts in the Seventh Circuit have utilized a four-part checklist to determine whether to

grant a protective order to prevent the deposition of an apex witness. Courts may protect high-

level executives from being deposed when any of four circumstances exist: (1) the official has “no

unique personal knowledge of the matter in dispute”; (2) the information can be garnered from

other witnesses or (3) other discovery methods; and (4) sitting for the deposition would impose a

hardship in light of the officer’s duties. Little v. JB Pritzker for Governor, No. 18 C 6954, 2020

WL 868528, at *1 (N.D. Ill. Feb. 21, 2020) (citing cases). However, “the apex doctrine…is not an

ironcladrule, but bespeaks sensitivity to the risk that very valuable executive time would be wasted

where the officer has no real information.” Dyson Inc. v. Sharkninja Operating LLC, No. 1:14-

CV-0779, 2016 WL 1613489, at *1 (N.D. Ill. Apr. 22, 2016) (internal quotes and citation omitted).

Mallinckrodt argues that Mr. Trudeau, as the President and CEO of Mallinckrodt PLCfrom

2013 to the present, was not personally involved in and thus has no knowledge of the alleged

events giving rise to Plaintiffs’ claims because those events occurred several years prior to

Mallinckrodt’s acquisition of Questcor in 2014 and Mr. Trudeau was never employed by Questcor.

Thus, they argue Mr. Trudeau lacks personal knowledge of the “core allegations about which

Plaintiffs will seek to obtain testimony to prove their claims.” Mallinckrodt’s Motion at 2,

Rockford Dkt. 328; MSP Dkt. 283.

It is true that the two main components of Rockford’s antitrust claims are their allegations

that Mallinckrodt conspired with Express Scripts in two areas: entering into an exclusive

distribution agreement for Acthar in 2007 and acquiring a potential competitive product

(Synacthen) in 2013. Rockford alleges that this resulted, in part, in the ability of Mallinckrodt to

raise Acthar prices exorbitantly.

However, Rockford did not begin to experience damages as a result of the alleged antitrust

conspiracy until 2015. Rockford’s Second Amended Complaint at 20, Rockford Dkt. 98. The

second amended complaint alleges that from 2015 through the time of filing of the second amended

complaint,Mallinckrodt has continued to increase the price of Acthar and that these price increases

are direct evidence that the antitrust violations continue. Id. at 23-24, 29. The second amended

complaint seeks injunctive relief to stop the ongoing antitrust violations. Id. at 3, 59; see Johnson

v. Jung, 242 F.R.D. 481, 484 (N.D. Ill. 2007) (observing that “personal involvement” is not a

prerequisite for deposing a corporate officer if the executive has knowledge of relevant facts).

Rockford alleges that as the current President and CEO, Mr. Trudeau has relevant

information concerning Mallinckrodt’s continuation of the antitrust conduct through the present.

Specifically, Rockford points to emails which tend to indicate that Mr. Trudeau was intimately

involved in the pricing strategy for Acthar.3 See Plaintiff’s Sealed Response, Rockford Dkt. 358.

In one emailfor example,Mr. Trudeau discusses the risks the company is facing regarding Acthar

and the possibility of increasing the price significantly. See Travelers Rental Co. v. Ford Motor

Co., 116 F.R.D. 140, 146 (D. Mass. 1987) (finding that information concerning corporate motive

or intent resides with executives with greatest level of authority).

Mallinckrodt did not file a supporting affidavit regarding Mr. Trudeau or otherwise deny

that he was significantly involved in Acthar strategy and pricing during his tenure. It argues only

that this strategy was discussed in emails that were sent to or reference other deponents or at a

meeting that over 21 other people were invited to, including several persons that Rockford is

already planning to depose. It is unclear how deposing these other individuals would shed more

light on the Acthar strategy than deposing the person who was involved in, if not responsible for,

setting the strategy, namely Mr. Trudeau. Depositions of other employees would not necessarily

overlap with Mr. Trudeau’s personal knowledge. See Minter v. Wells Fargo Bank, N.A., 258

F.R.D. 118, 127 (D. Md. 2009) (“First, the Court has concluded that Mr. Foster possesses some

unique and personal knowledge. Deposition of another is not a substitute. Second, while others

may share his knowledge on some subjects, there is no assertion that this deposition is

unreasonably cumulative or duplicative.”).

The Court must balance the competing interests in allowing this discovery and protecting

Mallinckrodt and Mr. Trudeau from undue burden. Even considering that Mr. Trudeau is the

highest-ranking executive of a multinational corporation,with costs clearly associated with having

to sit for a deposition,Mallinckrodt has not made the strong showing required for an outright denial

of the right to depose Mr. Trudeau where he is alleged to have direct knowledge of the conduct

underlying Rockford’sclaims. See Six West Retail Acquisition, Inc. v. Sony Theatre Mgmt. Corp.,

203 F.R.D. 98, 103-07 (S.D.N.Y. 2001) (compelling depositions of Chairman and other executives

because they were familiar with the pricing policies of Sony’s motion picture subsidiary that were

relevant to plaintiff’s antitrust claim and had some knowledge of allegedly anticompetitive

practices); In re Bridgestone/Firestone, Inc., Tires Prod. Liab. Litig., 205 F.R.D. 535, 536 (S.D.

Ind. 2002) (“Federal courts have permitted thedepositions of high level executives when conduct

and knowledge at the highest corporate levels of the defendant are relevant in the case.”).

3Mallinckrodt argues that Rockford’s reliance on Mr. Trudeau’spublic representations on behalf of

Mallinckrodt are inapposite citing Affinity Labs of Texas v. Apple, Inc., No. C 09-4436 CW JL, 2011 WL

1753982, at *16 (N.D. Cal. May 9, 2011).But unlike the party in Affinity,Rockfordhas alsopointed to

Mr. Trudeau’s unique, firsthand knowledge regardingissuesrelevantto its claims.Nevertheless, the

Court acknowledges that Rockfordhascited numerous documents that appear to have no relevance to

their claimsand no connection to relevance is sufficiently explained.

Moreover, Mallinckrodt has provided the Court with no basis to conclude that Plaintiffs

are seeking Mr. Trudeau’s deposition solely for harassment or abuse. See In re Bridgestone, 205

F.R.D. at 536 (finding that one rationale for barring deposition of an apex witness “is that high

level executives are vulnerable to numerous, repetitive, harassing, and abusive depositions, and

therefore need some measure of protection from the courts”). Mallinckrodt’s only claim for

harassment stems from Plaintiffs’ failure to depose other lower-level executives and employees

that were more closely tied to the relevant eventsbefore proceeding with Mr. Trudeau’s deposition.

At the hearing, Rockford’s counsel acknowledged the need to get to the apex by deposing

lower-level executives first. The Court agrees with this procedure. Plaintiffs should first attempt

to obtain the informationthey seek by deposing other lower-level executives and employees with

more knowledge of the relevant eventsin 2007 and 2013 as they relate to their claimsfor damages

and injunctive relief before deposing Mr. Trudeau. See Travelers, 116 F.R.D. at 145

(acknowledging the need to “permit deferment of the depositions of higher executives until

subordinates with supposedly equal or greater knowledge have been deposed”). In ordering that

these other depositions proceed first, theCourt is not otherwise limitingthe determination that Mr.

Trudeau’s deposition can proceed because he has unique personal knowledge relevant to the

claims. However, for Plaintiffs to distil and streamline the information they seek from Mr.

Trudeau, they should first proceed with other witnesses that might have more knowledge to narrow

the line of questioning necessary for Mr. Trudeau.

Mallinckrodt references 30 depositions that Plaintiffs intend to take of other Questcor and

Mallinckrodt employeesthat were likely to have been involved in the relevant events.Mallinckrodt

specifically identifies Don Bailey, Steve Cartt, Michael Mulroy, David Medeiros, Eldon Mayer,

and Hugh O’Neill. This may not be an exhaustive list, butthe Court is hopeful that the parties can

agree to a reasonable list of witnesses that should proceed before deposing Mr. Trudeau to limit

unnecessary questioningand lessen any resulting hardship.

As for the depositions of Mr. Paz and Mr. Wentworth, Express Scripts similarly seeks to

prevent Plaintiffs from taking these depositions entirely. The Court will first address a threshold

issue as toMr. Paz.

The Court finds that Express Scripts has not shown that Mr. Paz qualifies as an apex

witness in this case. Express Scripts has identified Mr. Paz as the former CEO and Chairman of

the Board of Express Scripts, Inc. The Court assumes that Mr. Paz remains as Chairman, but

Express Scripts has not identified whether Mr. Paz currently holds this position, or any other

position that would qualify him as an apex witness under the circumstances.4 See Minter v. Wells

4The Court notes that Express Scripts could have prevented any confusion by filing an affidavit

identifying Mr. Paz’s current position and responsibilities. However, Defendants have elected not to file

affidavits for any of the requested protective orders.

Fargo Bank, N.A., 258 F.R.D. 118, 126 (D. Md. 2009) (“While Mr. Foster is CEO of L & F, he

does not qualify as an ‘apex’ executive for the purposes of this case. . . . Mr. Foster has asserted

that he is no longer a busy corporate executive, but works a limited schedule. [ ] A deposition

would seemingly not interfere with any of his corporate responsibilities.”). It is not for this Court

to make arguments for the parties. Moreover, Express Scripts does not rely on Mr. Paz’s current

employment status or responsibilities to claim that a deposition would impose an unduehardship.

Compare Van Den Eng v. Coleman Co., No. 05-MC-109-WEB-DWB, 2005 WL 3776352, at *2

n.3 (D. Kan. Oct. 21, 2005) (finding that because the deponent was no longer working for Coleman

and had no corporate responsibilities, this militated against the application of the apex doctrine,

noting that the deponent’s “current occupation, if any, is unknown, and Defendants fail to even

argue that this deposition would interfere with any current responsibilities he might have”) with

Robertson v. McNeil-PPC Inc., No. LACV1109050JAKSSX, 2014 WL 12576817, at *17 (C.D.

Cal. Jan. 13, 2014) (“Given that Goggins, as the Worldwide Chairman of Johnson & Johnson’s

Consumer Group, was an executive at the highest level of the corporation, and that she currently

maintains other significant, corporate responsibilities, the apex doctrine applies.”). By contrast,

Express Scripts specifically argues that Mr. Wentworth’s duties as the current President of Express

Scripts Holding Co. place considerable constrains on his time.

Regardless, whether applying Rule 26 or the factors for apex witnesses, the Court finds

that Express Scripts has not made “a particular and specific demonstration of fact” as to the need

to completely preclude the depositions of either Mr. Paz orMr. Wentworth. See Gulf Oil Co., 452

U.S. at 102 n.16. Express Scripts makes the conclusory argument that Plaintiffs have not shown

that these individuals have unique personal knowledge.

Yet, it is Express Scripts’ burden to demonstrate that good cause exists to justify entry of

the requested protective order. Express Scripts has not filed affidavits from either executive

denying knowledge of relevant facts. Instead, Express Scripts generally argues that they have no

relevant knowledge because neither were identified in any of the parties’ initial disclosures, they

were not signatories to the 2007 agreement or any amendments, and Express Scripts does not

intend to call them at trial or offer their declarations in support of any “key” motions. Defendants’

Motion at 8, RockfordDkt. 326; MSPDkt. 281. This is not enough to show good cause to prevent

these depositions.

Express Scripts does not directly address the fact that Mr. Paz’s executive tenure with

Express Scripts from 1998 through 2015 overlaps with the two main components of Rockford’s

claims: the 2007 agreement and the 2013 acquisition. Rockford also point to evidence indicating

that Mr. Paz was involved in Acthar strategy following Mallinckrodt’s purchase of Questcor in

2014 when attending meetings with Mr. Trudeau. See Travelers Rental Co., 116 F.R.D. at 146

(finding that information concerning corporate motive or intent resides with executives with

greatest level of authority). Express Scripts also generally alleges that Plaintiffs merely identify

these individuals on email distribution lists that discuss Acthar. However, Rockford has pointed to

an email which tends to indicate that Mr. Wentworth had some level on knowledge about pricing

strategy. See Six West Retail Acquisition, Inc., 203 F.R.D. at 103-07 (compelling depositions of

Chairman and other executives because they were familiar with the pricing policies of Sony’s

motion picture subsidiary that were relevant to plaintiff’s antitrust claim and had some knowledge

of allegedly anticompetitive practices); see also City of Rockford v. Mallinckrodt ARD, Inc., No.

17 C 50107, 2019 WL 2763181, at *2 (N.D. Ill. May 3, 2019) (“[A]n express agreement among

all the conspirators is not a necessary element of a civil conspiracy. The participants in the

conspiracy must share the general conspiratorial objective, but they need not know all the details

of the plan designed to achieve the objective or possess the same motives for desiring the intended

conspiratorial result.”) (quotation marks and citation omitted).

The Court will not grant the extraordinary relief of completely prohibiting the depositions

of Mr. Paz and Mr. Wentworth where Express Scripts has not shown that taking their depositions

would impose an undue hardship or that these individuals otherwise have no knowledge relevant

to the claims. See Nucap, 2017 WL 6059770, at *4. Moreover, Express Scripts’ only claim for

harassment or abuse is that by not seeking any written discovery regarding Mr. Paz or Mr.

Wentworth’s alleged involvement in, or knowledge of, the acts giving rise to their claims, Plaintiffs

must be seeking these depositions to place undue pressure on theindividuals and Express Scripts.

However, Express Scripts has provided no evidence of any such abuse or harassment.

Even considering whether the information could be obtained from other witnesses or

discovery methods, Rockford hasprovided enoughevidenceproduced in discoveryto indicate that

both Mr. Paz and Mr. Wentworth are likely to have unique personal knowledge of relevant

information. This is not a situation where Rockford needs to conduct additional discovery to

determine whether Mr. Paz or Mr. Wentworth have relevant knowledge. See, e.g., Patterson, 281

F.3d at 681 (affirming district judge’s refusal to compel deposition of high-ranking executive, in

part, because a deposition, as opposed to interrogatories, “would have been a quite costly and

burdensome means for determining whether [the executive] had information bearing on [the

plaintiff’s] termination”).

Nevertheless, in light of Express Scripts’ assertion that Mr. Wentworth’s time is

significantly constrained by his current duties as President of Express Scripts Holding Co., the

Court agrees with Express Scripts that Plaintiffs should first proceed with the already-noticed

depositions of individuals that were directly tied to the decisions underlying Rockford’s claims.

Again, this Court’s determination that other witnesses with more knowledge should be deposed

before proceeding to depose Mr. Wentworth is an attempt to lessen any resulting hardship by

narrowing the questionsposed, and as a result,the length of hisdeposition.The Court clarifies that

Express Scripts has not shown any undue burden that would justify precluding Mr. Wentworth’s

deposition.

Express Scripts generally identifies 25 current and former executives and employees of

Express Scripts, individuals identified in their initial disclosures, and signatories of the relevant

contracts as witnesses with the same or more knowledge regarding the alleged facts underlying

Rockford’s claims. Express Scripts also specifically identifies David Norton, Everett Neville,

Steve Miller, and the current and former Presidents of CuraScript. Plaintiffs shall first proceed

with already-noticed depositions of witnesses with the most relevant knowledge of the alleged

events to streamline their approach before proceeding with Mr. Wentworth’s deposition. Because

Express Scripts has not identified any hardship in proceeding with Mr. Paz’s deposition, the Court

will not require Plaintiffs to depose any other witnesses before proceeding.

Therefore, Defendants’ motions for protective order are denied, except to the extent this

Court orders other depositions to proceed before the depositions of Mr. Trudeau and Mr.

Wentworth. Rockford Dkts. 326, 328; MSP Dkts. 281, 283.

Date: April 6, 2020 By: x 4 : Z _

Lisa A. Jensen

United States Magistrate Judge

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.